The license acquisition from GlaxoSmithKline (GSK) for the pharmaceutical product Tamarine® in the Italian market, as well as the trademark for 30 international markets, opens the door for new prospects for Gerolymatos International.
Sinomarin® is always at the frontline. Launched in 1997 as the first hypertonic sea water nasal solution in the market, today, Sinomarin® launches a new innovation, set to place the brand in the health news headlines.
Gerolymatos International had the pleasure of hosting its Sinomarin partners from 30 of its International markets in a 3-day event in Heraklion, Crete that perfectly combined business and leisure.
CPhI Worldwide is the world’s leading European pharmaceutical exhibition bringing together more than 37.000 pharma industry professionals from more than 150 countries with more than 2.500 exhibitors.